已经合成了一系列的单取代的4-苯基哌啶和-哌嗪,并在体内测试了它们对多巴胺能系统的作用。结构活性关系(SAR)表明,芳香取代基的位置和理化特性对自由运动大鼠大脑中3,4-二羟基苯基乙酸(DOPAC)的水平至关重要。为了研究这些化合物的结构特性如何影响响应,使用偏最小二乘(PLS)回归对一组列表化和计算的物理化学描述符针对体内效应进行了建模。此外,与多巴胺D 2(DA D 2确定了所选子集的受体和单胺氧化酶A(MAO A)酶,并使用与体内模型相同的描述语来描述QSAR模型,以研究导致观察到的DOPAC反应的机制。这些模型与纹状体DOPAC的水平与对DA D 2和MAO A的亲和力之间的强相关性相结合,提供了对该类化合物生物学反应的全面理解。
[EN] BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES USEFUL IN THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS [FR] DERIVES DE BENZOFURANE ET DE BENZOTHIOPHENE UTILISES DANS LE TRAITEMENT DE TROUBLES HYPERPROLIFERATIFS
[EN] BENZOFURAN DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS<br/>[FR] DERIVES DE BENZOFURANE UTILISES POUR TRAITER DES TROUBLES HYPERPROLIFERANTS
申请人:BAYER PHARMACEUTICALS CORP
公开号:WO2005014566A1
公开(公告)日:2005-02-17
The invention relates to novel heterocycles of formula (I), processes for their preparation and their use for preparing medicaments for the treatment or prophylaxis of disorders, especially of hyperproliferative disorders.
[EN] AMINE DERIVATIVES AS POTASSIUM CHANNEL BLOCKERS<br/>[FR] DÉRIVÉS D'AMINE AGISSANT COMME BLOQUEURS DU CANAL POTASSIUM
申请人:BIONOMICS LTD
公开号:WO2012155199A1
公开(公告)日:2012-11-22
The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation.
Rational Design and Synthesis of Selective PRMT4 Inhibitors: A New Chemotype for Development of Cancer Therapeutics**
作者:Mathew Sutherland、Alice Li、Anissa Kaghad、Dimitrios Panagopoulos、Fengling Li、Magdalena Szewczyk、David Smil、Cora Scholten、Léa Bouché、Timo Stellfeld、Cheryl H. Arrowsmith、Dalia Barsyte、Masoud Vedadi、Ingo V. Hartung、Holger Steuber、Robert Britton、Vijayaratnam Santhakumar
DOI:10.1002/cmdc.202100018
日期:2021.4.8
interest in the discovery of inhibitors as biological tools and, potentially, therapeutics. Although several PRMT4 inhibitors have been reported, most display poor selectivity against other members of the PRMT family of methyl transferases. Herein, we report the structure‐based design of a new class of alanine‐containing 3‐arylindoles as potent and selective PRMT4 inhibitors, and describe key structure–activity
Benzofuran derivatives useful for treating hyper-proliferative disorders
申请人:Zhang Chengzhi
公开号:US20060194816A1
公开(公告)日:2006-08-31
The invention relates to novel heterocycles of formula (I), processes for their preparation and their use for preparing medicaments for the treatment or prophylaxis of disorders, especially of hyperproliferative disorders.
BENZOFURAN DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS
申请人:Zhang Chengzhi
公开号:US20090023783A1
公开(公告)日:2009-01-22
The invention relates to novel benzofuran derivatives, processes for their preparation and their use for preparing medicaments for the treatment or prophylaxis of disorders, especially of hyperproliferative disorders